Literature DB >> 14707593

Mediator modulation therapy of severe sepsis and septic shock: does it work?

R Phillip Dellinger, Joseph E Parrillo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14707593     DOI： 10.1097/01.CCM.0000105423.06091.8E

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  10 in total

1.  The helminth product ES-62 protects against septic shock via Toll-like receptor 4-dependent autophagosomal degradation of the adaptor MyD88.

Authors:  Padmam Puneet; Mairi A McGrath; Hwee Kee Tay; Lamyaa Al-Riyami; Justyna Rzepecka; Shabbir M Moochhala; Shazib Pervaiz; Margaret M Harnett; William Harnett; Alirio J Melendez
Journal:  Nat Immunol       Date:  2011-02-27       Impact factor: 25.606

Review 2.  Oncology Drug Repurposing for Sepsis Treatment.

Authors:  Izabela Rumienczyk; Maria Kulecka; Małgorzata Statkiewicz; Jerzy Ostrowski; Michal Mikula
Journal:  Biomedicines       Date:  2022-04-17

Review 3.  Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials.

Authors:  Stephen Trzeciak; Ismail Cinel; R Phillip Dellinger; Nathan I Shapiro; Ryan C Arnold; Joseph E Parrillo; Steven M Hollenberg
Journal:  Acad Emerg Med       Date:  2008-05       Impact factor: 3.451

Review 4.  Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective.

Authors:  Manu Shankar-Hari; Jo Spencer; William A Sewell; Kathryn M Rowan; Mervyn Singer
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

5.  Statin therapy in critical illness: an international survey of intensive care physicians' opinions, attitudes and practice.

Authors:  Manu Shankar-Hari; Peter S Kruger; Stefania Di Gangi; Damon C Scales; Gavin D Perkins; Danny F McAuley; Marius Terblanche
Journal:  BMC Clin Pharmacol       Date:  2012-06-28

6.  Chitohexaose activates macrophages by alternate pathway through TLR4 and blocks endotoxemia.

Authors:  Santosh K Panda; Sunil Kumar; Nitin C Tupperwar; Tushar Vaidya; Anna George; Satyajit Rath; Vineeta Bal; Balachandran Ravindran
Journal:  PLoS Pathog       Date:  2012-05-24       Impact factor: 6.823

7.  The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems.

Authors:  Benjamin Vandendriessche; Elke Rogge; Vera Goossens; Peter Vandenabeele; Johannes-Peter Stasch; Peter Brouckaert; Anje Cauwels
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

8.  Trichinella spiralis excretory-secretory products protect against polymicrobial sepsis by suppressing MyD88 via mannose receptor.

Authors:  Linlin Du; Lihua Liu; Yang Yu; Hui Shan; Leiqing Li
Journal:  Biomed Res Int       Date:  2014-06-26       Impact factor: 3.411

Review 9.  Helminths and their implication in sepsis - a new branch of their immunomodulatory behaviour?

Authors:  Marc P Hübner; Laura E Layland; Achim Hoerauf
Journal:  Pathog Dis       Date:  2013-09-10       Impact factor: 3.166

10.  Mitochondria-Targeted Antioxidants SkQ1 and MitoTEMPO Failed to Exert a Long-Term Beneficial Effect in Murine Polymicrobial Sepsis.

Authors:  Pia Rademann; Adelheid Weidinger; Susanne Drechsler; Andras Meszaros; Johannes Zipperle; Mohammad Jafarmadar; Sergiu Dumitrescu; Ara Hacobian; Luisa Ungelenk; Franziska Röstel; Jozsef Kaszaki; Andrea Szabo; Vladimir P Skulachev; Michael Bauer; Soheyl Bahrami; Sebastian Weis; Andrey V Kozlov; Marcin F Osuchowski
Journal:  Oxid Med Cell Longev       Date:  2017-09-19       Impact factor: 6.543
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.